Users may experience increased energy levels, improved sleep quality, reduced appetite, and enhanced mood
Both are dominated by gastrointestinal adverse events nausea, vomiting, diarrhea, constipation, and abdominal pain that are mostly mild to moderate and concentrate during dose escalation
When administered under medical supervision, glutathione injections support intracellular antioxidant defence
While both peptides show remarkable promise individually, their potential combination raises critical questions about dosing protocols, safety considerations, and therapeutic rationale that demand careful examination
only the first amino acid differs ( glycine in GHK-Cu vs alanine in AHK-Cu)